LPCN

Lipocine Inc. (LPCN) PESTLE Analysis Analysis (2026)

Invetso Score: 5.8/10 — Balanced · Last Updated: 2026-09-01

Overall Score

Political

No material political catalysts or policy changes were identified this month.

Economic

The company remains unprofitable on a TTM basis, with negative operating and free cash flow margins.

Liquidity is strong with a current ratio of 11.48 and cash per share of 2.83, which helps offset ongoing losses.

Valuation remains elevated on sales at 12.82x EV/Sales despite negative earnings and cash flow.

Social

No material social or demand-side developments were identified this month.

Technological

R&D intensity remains high at 6.49% of revenue, supporting ongoing product development.

Gross margin is very strong at 98.1%, indicating a potentially attractive product economics profile if commercialization scales.

Legal

No material legal or regulatory developments were identified this month.

Environmental

No material environmental developments were identified this month.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Lipocine Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →